期刊文献+

临床药师参与依替米星致重症大疱型药疹治疗方案制定1例分析 被引量:4

Analysis of One Case of Clinical Pharmacists Participating in Treatment Options for Severe Bullous Drug Eruptions Caused by Etimicin
原文传递
导出
摘要 目的探讨临床药师在依替米星致患者重症大疱型药疹治疗过程中的作用。方法临床药师对产生重症大疱型药疹可疑药物的关联性判断、抗感染方案的制定等方面提供建议,协助临床医师制定治疗方案。结果医师采纳临床药师建议,治疗过程顺利,患者症状好转出院。结论临床药师参与患者个体化用药方案的制定,促进了临床合理用药,确保患者用药安全。 OBJECTIVE To explore the role of clinical pharmacists in treatment options for the patient with severe bullous drug eruptions caused by etimicin.METHODS The clinical pharmacists provided advice on the association of the suspected drugs that resulted in severe bullous drug eruptions and the formulation of anti-infective agent,and assisted the clinicians in setting treatment plans.RESULTS Physicians adopted the suggestions of clinical pharmacists,the treatment was carried out smoothly,the patients symptoms were better than before,and discharged from the hospital.CONCLUSION The participation of clinical pharmacists in the formulation of individual medication plan,which promotes rational drug use and guarantee the safety of drug use.
作者 黄艳芳 王小双 吴柳婷 HUANG Yanfang;WANG Xiaoshuang;WU Liuting(Puren Hospital Affiliated to Wuhan Science&Technology University,Wuhan 430081,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2019年第10期1264-1267,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 依替米星 重症大疱型药疹 临床药师 etimicin severe bullous drug eruptions clinical pharmacist
  • 相关文献

参考文献14

二级参考文献161

共引文献207

同被引文献33

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部